<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04160429</url>
  </required_header>
  <id_info>
    <org_study_id>18380</org_study_id>
    <secondary_id>NCI-2019-07380</secondary_id>
    <secondary_id>18380</secondary_id>
    <nct_id>NCT04160429</nct_id>
  </id_info>
  <brief_title>Biospecimen Analysis in Detecting Chemical Concentrations in Patients With Chronic or Infectious Diseases Receiving Meditations</brief_title>
  <official_title>Pilot Study to Evaluate Substances in Sweat, Saliva, and Blood</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>City of Hope Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>City of Hope Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial collects and analyzes sweat and saliva samples compared to blood in detecting&#xD;
      chemical concentrations in the body in patients with chronic or infectious diseases receiving&#xD;
      medications. Wearable sweat sensors are capable of monitoring electrolytes and metabolites&#xD;
      (sodium, potassium, glucose, lactate, etc.) for health monitoring and disease diagnosis.&#xD;
      Designing wearable sweat sensors capable of providing information regarding drug&#xD;
      administration may be challenging due to ultralow concentrations in biofluids. This trial&#xD;
      seeks to determine if the use of a smart wristband can accurately measure the levels of&#xD;
      chemicals and substances in sweat.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVE:&#xD;
&#xD;
      I. To compare novel, home-based methods of quantitating medication concentrations in either&#xD;
      saliva or sweat to the 'gold standard' of liquid chromatography - mass spectrometry of&#xD;
      plasma.&#xD;
&#xD;
      SECONDARY OBJECTIVES:&#xD;
&#xD;
      I. To compare novel home-based methods of quantitating substances in either saliva or sweat&#xD;
      to the 'gold standard' in plasma.&#xD;
&#xD;
      II. Assess the ease of obtaining home-based samples.&#xD;
&#xD;
      OUTLINE:&#xD;
&#xD;
      Patients undergo collection of sweat samples via Macroduct Sweat Collection System 3710S and&#xD;
      saliva and blood samples within 24 hours after medication administrations. Patients also&#xD;
      complete questionnaires over 5-10 minutes and have medical charts reviewed.&#xD;
&#xD;
      After completion of study, patients are followed up periodically.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    pending amendment approval&#xD;
  </why_stopped>
  <start_date type="Actual">November 9, 2018</start_date>
  <completion_date type="Anticipated">December 9, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 9, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Predictive performance of the home-based sampling</measure>
    <time_frame>Up to 4 hours</time_frame>
    <description>Will be assessed by Pearson correlation and quantification of the predictive performance. The predictive performance of the home-based sampling methods will be assessed by calculating the median percentage prediction error (MPPE).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Observed plasma concentrations</measure>
    <time_frame>Up to 4 hours</time_frame>
    <description>Will be assessed by Pearson correlation and quantification of the predictive performance. The values from plasma will be considered the observed concentration.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Chronic Disease</condition>
  <condition>Infectious Disorder</condition>
  <arm_group>
    <arm_group_label>Device feasibility (Macroduct Sweat Collection System)</arm_group_label>
    <description>Patients undergo collection of sweat samples via Macroduct Sweat Collection System 3710S and saliva and blood samples within 24 hours after medication administrations. Patients also complete questionnaires over 5-10 minutes and have medical charts reviewed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Biospecimen Collection</intervention_name>
    <description>Undergo collection of sweat, saliva, and blood samples</description>
    <arm_group_label>Device feasibility (Macroduct Sweat Collection System)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Medical Chart Review</intervention_name>
    <description>Review of medical chart</description>
    <arm_group_label>Device feasibility (Macroduct Sweat Collection System)</arm_group_label>
    <other_name>Chart Review</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire Administration</intervention_name>
    <description>Complete questionnaire</description>
    <arm_group_label>Device feasibility (Macroduct Sweat Collection System)</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Sweat, saliva, and blood&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with chronic or infectious diseases scheduled to receive medications&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Scheduled to receive medications including, but not limited to, cyclophosphamide,&#xD;
             mycophenolic acid, mycophenolate mofetil, metformin or busulfan (any dose, any number&#xD;
             of doses, any dosing frequency) as part of treatment at any time. Patients with&#xD;
             chronic or infectious diseases can participate&#xD;
&#xD;
          -  Willingness to:&#xD;
&#xD;
               -  Provide blood, sweat, and saliva samples&#xD;
&#xD;
               -  Permit medical record review&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pilocarpine allergy&#xD;
&#xD;
          -  Difficulty with understanding written English&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeannine S McCune</last_name>
    <role>Principal Investigator</role>
    <affiliation>City of Hope Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>City of Hope Medical Center</name>
      <address>
        <city>Duarte</city>
        <state>California</state>
        <zip>91010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>November 8, 2019</study_first_submitted>
  <study_first_submitted_qc>November 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 13, 2019</study_first_posted>
  <last_update_submitted>January 26, 2021</last_update_submitted>
  <last_update_submitted_qc>January 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Infections</mesh_term>
    <mesh_term>Chronic Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

